Xenon Pharmaceuticals Inc.XENENASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-279.30M
↓ 217% below average
Average (9y)
$-88.04M
Historical baseline
Range
High:$-9.36M
Low:$-279.30M
CAGR
+45.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-279.30M | -30.5% |
| 2023 | $-214.05M | -65.7% |
| 2022 | $-129.14M | -63.5% |
| 2021 | $-78.99M | -152.4% |
| 2020 | $-31.30M | +26.9% |
| 2019 | $-42.82M | -12.6% |
| 2018 | $-38.02M | -16.7% |
| 2017 | $-32.58M | -31.3% |
| 2016 | $-24.82M | -165.1% |
| 2015 | $-9.36M | - |